an overview of osteoporosis, including fragility fractures, how to identify at-risk populations, the impact of osteoporosis and current gaps in osteoporosis care.
Osteoporosis is a disease characterised by low bone mass and structural deterioration of bone tissue leading to an increase in bone fragility and susceptibility to fracture.
It is a progressive and asymptomatic disease that usually presents only after a fracture has occurred
more info click here
A fragility fracture results from mechanical forces that would not ordinarily result in fracture, known as low level (or ‘low energy’) trauma.1
An osteoporotic fracture is a fragility fracture that has occurred as a consequence of osteoporosis. It is defined as ‘fracture associated with low bone mineral density’.
Important! Osteopenia is the stage before osteoporosis when a bone density scan shows lower bone density than the average for the patient’s age, but not low enough to be classed as osteoporosis.4 Osteopenia does not always lead to osteoporosis.
Low level trauma = forces equivalent to a fall from a standing height or less
More Health Awareness posts blog
Osteoporosis affects 3 million people in the UK and over 500,000 people are hospitalised due to fragility fractures every year. 1 in 2 women and 1 in 5 men over the age of 50 are expected to break a bone in their lifetime because of osteoporosis.
Hip fracture is the most common reason for admission to orthopaedic wards with an estimated UK annual incidence of 101,000 in 2020. It is usually caused by an osteoporotic fragility fracture in an older person with osteoporosis and osteopenia.
Hip fractures are associated with high mortality; 6.7% in the first month and approximately 33% at 12 months. This is in part because many of these people have other long-term conditions or may be living with frailty, rather than the hip fracture itself.
Up to 75% of patients are admitted from home and approximately 10–20% of those will move to institutional care. This figure has been projected to be up to 15,000 patients in 2020.
Direct medical costs from fragility fractures to the UK healthcare economy were estimated £1.8 billion in 2000 and are expected to increase to £2.2 billion by 2025, and with most of these costs relating to hip fracture care.
The rising burden of fragility fractures in the UK
Type of fracture | 2010 | 2025 |
---|---|---|
Hip fractures | 79,000 | 102,000 |
Vertebral fractures | 66,000 | 84,000 |
Forearm fractures | 69,000 | 84,900 |
Other fractures | 322,000 | 411,300 |
Total fractures | 536,000 | 682,000 |
Less than one third of the patients experiencing the estimated 500,000 fragility fractures per year receive bone protecting treatments.
The economic burden of osteoporosis in the UK |
---|
The cost of osteoporosis (excluding value of QALYs lost) is estimated to rise from £4.4 billion in 2010 to £5.5 billion in 2025.
The cost of osteoporosis including value of QALYs lost is estimated to increase from approximately £11.5 billion in 2010 to £14.0 billion in 2025.
More Health Awareness posts blog
NICE recommend those who have experienced a fragility fracture should have their risk of fracture assessed.
In 2016, 97% of hip fracture patients received a bone health assessment. However, treatment was assessed as inappropriate in 21.6% of those patients.
Most osteoporotic fractures occur in women who do not meet the WHO definition of osteoporosis |
---|
The WHO defines osteoporosis as a bone mineral density of 2.5 standard deviations below the mean peak mass (average of young healthy women) as measured by dual-energy X-ray absorptiometry applied to the femoral neck and reported as a T-scoreT-score of -2.5 or below = osteoporosisT-score between -1.0 and -2.5 = low bone density or osteopeniaT-score of -1.0 or above = normal bone density |
Patients are not receiving bone protecting treatment |
---|
Less than one third of patients in the UK experiencing the estimated 500,000 fragility fractures per year receive bone protecting treatments21% of patients receiving bone health assessments are not being treated with bone protection |
Adherence to osteoporosis treatments are low |
---|
At 3 months, 74% of patients continue to take their medicinesAt 12 months, only 14% of patients are adhering to their medicines |
The proportion of older people is increasing |
---|
In 1998, 15.9% of patients were 65 years or olderIn 2018, 18.3% of patients were 65 years or olderIn 2038, 24.2% of patients are expected to be 65 years or olderOne third of over 65s fall at least once each year and 255,000 result in emergency admission |
Important! Identifying patients in a systematic way could prevent up to a quarter of all hip fractures, which equates to almost 20,000 hip fractures a year.
NICE. NICE impact falls and fragility fractures. July 2018.
The possibility that a person may die within the next few days or hours should be recognised and communicated clearly. Decisions should then be made and actions taken in accordance with the person’s needs and wishes. These should be regularly reviewed and decisions revised accordingly. Sensitive communication should take place between healthcare professionals and the dying person, and those identified as important to them. The dying person, and those identified as important to them, should be involved in decisions about treatment and care to the extent that the dying person wants. The needs of families and others identified as important to the dying person should be actively explored, respected and met as far as possible. An individual tailored plan of care should be agreed, coordinated and delivered with compassion.This includes support to eat and drink as long as they wish to do so, as well as symptom control and psychological, social and spiritual support to ensure their comfort and dignity.
Shifa4All is one of the best Pakistan’s Healthcare Service provider. Shifa4All has PMC verified Doctors with more than 20 years of International Health care experience in the fields of General/Internal Medicine, Geriatric Medicine, Frailty, Palliative, End of life care, Rehabilitation Medicine and family Medicine. Experienced in the management of Dementia Patients, Stroke & Heart Diseases.